ebselen has been researched along with Plasma Cell Tumor in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with ebselen did not reduce the antitumor activity of cisplatin against MPC 11 plasmacytoma or Prima breast tumor in BALB/c mice." | 1.28 | Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen. ( Baldew, GS; de Goeij, JJ; Los, G; McVie, JG; van der Valk, MA; Vermeulen, NP, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldew, GS | 1 |
| McVie, JG | 1 |
| van der Valk, MA | 1 |
| Los, G | 1 |
| de Goeij, JJ | 1 |
| Vermeulen, NP | 1 |
1 other study available for ebselen and Plasma Cell Tumor
| Article | Year |
|---|---|
Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Azoles; Cisplatin; Drug Adm | 1990 |